About Kelsey Bennett

Posts by Kelsey Bennett:

Vice Chair and Associate Vice Chair for Innovation and Commercialization Announced

Vice Chair and Associate Vice Chair for Innovation and Commercialization Announced

Drs. Pankaj Jay Pasricha and Kieren Marr were named the Vice Chair and Associate Vice Chair for Innovation and Commercialization, respectively, beginning June 15, 2015. In these roles, they will work to foster a culture of innovation in the department and help create pathways to turn scholarly activity of our scientists and clinician-scientists into products(...)

Read More

Atypical HUS may become a diagnosis of inclusion

Atypical HUS may become a diagnosis of inclusion

ARTICLE: Atypical HUS may become a diagnosis of inclusion AUTHORS: J. Evan Sadler JOURNAL: Blood. 2015 Jun 4;125(23):3525-6. doi: 10.1182/blood-2015-04-640656 Patients with aHUS usually have microangiopathic hemolytic anemia, thrombocytopenia, and renal failure. However, these features occur in many diseases, including thrombotic thrombocytopenic purpura (TTP), and the more common form of Shiga toxin–expressing Escherichia coli hemolytic(...)

Read More

Journeys in Medicine Implicit/Unconscious Bias

Journeys in Medicine Implicit/Unconscious Bias

On Wednesday, June 3, Mr. James Page, vice president and chief diversity officer for Johns Hopkins Medicine, gave an interactive discussion and presentation in order to spread awareness of unconscious bias and the potential negative impact it may have when interacting with colleagues and patients. Mr. Page gave examples of how different people may interpret(...)

Read More

Community Volunteer Opportunities


Many of our faculty and staff members have been asking about opportunities to volunteer in the community surrounding the East Baltimore campus. The Henderson-Hopkins school, a partnership between the Johns Hopkins University School of Education and Baltimore City Public Schools, recently asked for volunteer support from the Johns Hopkins Medicine community. Below are a few(...)

Read More

Ebola Response Team Earns MHA’s Distinguished Service Award

Ebola Response Team Earns MHA’s Distinguished Service Award

At its annual meeting on Tuesday, June 2, the Maryland Hospital Association presented the Distinguished Service Award to the Ebola Response Team here at Johns Hopkins Hospital. The Distinguished Service Award is the MHA’s highest honor and was given to caregivers at the three hospitals designated as Maryland’s Ebola treatment centers: Johns Hopkins Hospital, MedStar(...)

Read More

Sanofi iAwards Program Initiative

Sanofi iAwards Program Initiative

Sanofi and the Johns Hopkins School of Medicine will launch the Sanofi Innovation Awards (Sanofi iAwards) program, on Wednesday, June 10 from 5-6 p.m. in the Sheikh Zayed Tower, room 2119A. The event is open to everyone and will be followed by a reception. Sanofi is a leading global healthcare company engaged in the research, development,(...)

Read More

Mid-Career Faculty Career Development Seminar


The Association of American Medical Colleges will launch a new professional development program for mid-career minority faculty on September 18-19 at the Westin Buckhead Atlanta in Atlanta Georgia. The Department of Medicine Diversity Council will assist with travel expenses for one mid-career faculty member who is accepted to attend. This seminar will address the specific(...)

Read More

American Thoracic Society Awards

American Thoracic Society Awards

Roy Brower, professor in the Division of Pulmonary and Critical and Care Medicine, was recently awarded the Lifetime Achievement Award from the Critical Care Assembly of the American Thoracic Society. This award signifies a career devoted to research and teaching of the science and practice of critical care medicine and outstanding service to the assembly(...)

Read More

Phosphorus-32, a Clinically Available Drug, Inhibits Cancer Growth by Inducing DNA Double-Strand Breakage

Phosphorus-32, a Clinically Available Drug, Inhibits Cancer Growth by Inducing DNA Double-Strand Breakage

ARTICLE: Phosphorus-32, a Clinically Available Drug, Inhibits Cancer Growth by Inducing DNA Double-Strand Breakage AUTHOURS: Yulan Cheng, Ana P. Kiess, Joseph M. Herman, Martin G. Pomper, Stephen J. Meltzer, John M. Abraham JOURNAL: PLoS One. 2015 Jun 1;10(6):e0128152. doi: 10.1371/journal.pone.0128152. eCollection 2015. Abstract Radioisotopes that emit electrons (beta particles), such as radioiodine, can effectively kill(...)

Read More